{"transactions":[{"id":2494019,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"W Warrants","published_at":"2021-11-26T17:01:05.000Z","date":"2021-11-23","kind":"other","acquired":false,"shares":3000000,"ownership":{"direct":false,"nature":"HCFP/Capital Partners 18B-2 LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC (\"HCFP 18B-2\"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2021-10-01","expiration_date":"2026-09-30","underlying":"B Unit","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001104659-21-144009","document":"tm2133885-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921144009/tm2133885-1_4.xml","form_type":"4"}},{"id":2587647,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-27T18:02:01.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":200,"price":5,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.99 to $5.02 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":119997,"source":{"system":"sec-edgar","filing":"0001104659-21-110652","document":"tm2126367-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921110652/tm2126367-1_4seq1.xml","form_type":"4"}},{"id":2587646,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-27T18:02:01.000Z","date":"2021-08-26","kind":"purchase","acquired":true,"shares":200,"price":4.9,"value":980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.89 to $4.91 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":119797,"source":{"system":"sec-edgar","filing":"0001104659-21-110652","document":"tm2126367-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921110652/tm2126367-1_4seq1.xml","form_type":"4"}},{"id":2593240,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-08-23T17:55:11.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":800,"price":4.04,"value":3232.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.08 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":119597,"source":{"system":"sec-edgar","filing":"0001104659-21-108657","document":"tm2125722-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921108657/tm2125722-1_4seq1.xml","form_type":"4"}},{"id":2616699,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"W Warrants","published_at":"2021-08-03T18:49:13.000Z","date":"2021-07-31","kind":"other","acquired":true,"shares":1068016,"ownership":{"direct":false,"nature":"SCPS/Strategic Capital Partners LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Lamstein is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Lamstein disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents W Warrants held by SCPS/Strategic Capital Partners LLC, of which Mr. Lamstein is a co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the securities held by such entity. Mr. Lamstein disclaims beneficial ownership of such securities, except to the extent of his proportionate pecuniary interest therein."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027."}],"balance_after":1068016,"derivative":{"exercise_price":4,"exercise_date":"2021-10-01","expiration_date":"2026-09-30","underlying":"B Unit","underlying_shares":1068016},"source":{"system":"sec-edgar","filing":"0001104659-21-099626","document":"tm2123824d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921099626/tm2123824d2_4.xml","form_type":"4"}},{"id":2616698,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"W Warrants","published_at":"2021-08-03T18:49:13.000Z","date":"2021-07-31","kind":"other","acquired":true,"shares":16963,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the W Warrants issued upon conversion of the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date. No additional consideration was required in connection with such conversion."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the W Warrants issued upon conversion of the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date. No additional consideration was required in connection with such conversion."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F4","text":"Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 14,168 W Warrants that were previously reported on the reporting person's Form 3 filed with the SEC on December 15, 2020."}],"balance_after":31131,"derivative":{"exercise_price":4,"exercise_date":"2021-10-01","expiration_date":"2026-09-30","underlying":"B Unit","underlying_shares":16963},"source":{"system":"sec-edgar","filing":"0001104659-21-099626","document":"tm2123824d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921099626/tm2123824d2_4.xml","form_type":"4"}},{"id":2616697,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"Convertible Notes","published_at":"2021-08-03T18:49:13.000Z","date":"2021-07-31","kind":"exercise","acquired":false,"reported_value":8481,"ownership":{"direct":true},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"Represents the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date that were converted into W Warrants on such date. No additional consideration was required in connection with such conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the total outstanding principal amount and accrued interest on the Convertible Notes through and including the Maturity Date that were converted into W Warrants on such date. No additional consideration was required in connection with such conversion."}],"derivative":{"exercise_price":0.5,"exercise_date":"2020-04-09","expiration_date":"2021-07-31","underlying":"W Warrant","underlying_shares":16963},"source":{"system":"sec-edgar","filing":"0001104659-21-099626","document":"tm2123824d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921099626/tm2123824d2_4.xml","form_type":"4"}},{"id":2616696,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman"}}],"security":"Convertible Notes","published_at":"2021-08-03T18:49:13.000Z","date":"2021-07-31","kind":"other","acquired":true,"reported_value":981,"ownership":{"direct":true},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"Represents accrued interest on the Convertible Notes through and including July 31, 2021 (the \"Maturity Date\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents accrued interest on the Convertible Notes through and including July 31, 2021 (the \"Maturity Date\")."}],"derivative":{"exercise_price":0.5,"exercise_date":"2020-04-09","expiration_date":"2021-07-31","underlying":"W Warrant","underlying_shares":1963},"source":{"system":"sec-edgar","filing":"0001104659-21-099626","document":"tm2123824d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921099626/tm2123824d2_4.xml","form_type":"4"}},{"id":2623597,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-07-27T16:59:01.000Z","date":"2021-07-23","kind":"purchase","acquired":true,"shares":1500,"price":4.71,"value":7065.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":118797,"source":{"system":"sec-edgar","filing":"0001104659-21-096342","document":"tm2123355-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921096342/tm2123355-1_4seq1.xml","form_type":"4"}},{"id":2834996,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-24T07:54:28.000Z","date":"2021-02-23","kind":"purchase","acquired":true,"shares":500,"price":9.34,"value":4670.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":117297,"source":{"system":"sec-edgar","filing":"0001104659-21-027151","document":"tm217761-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921027151/tm217761-2_4seq1.xml","form_type":"4"}},{"id":2838020,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-23T08:04:47.000Z","date":"2021-02-22","kind":"purchase","acquired":true,"shares":100,"price":9.99,"value":999.0,"ownership":{"direct":true},"balance_after":116797,"source":{"system":"sec-edgar","filing":"0001104659-21-026467","document":"tm217579d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921026467/tm217579d2_4seq1.xml","form_type":"4"}},{"id":2845406,"issuer":{"id":133074,"kind":"organization","name":"Scopus BioPharma Inc.","symbol":"SCPS"},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock, par value $0.001","published_at":"2021-02-19T10:12:23.000Z","date":"2021-02-19","kind":"purchase","acquired":true,"shares":500,"price":10.93,"value":5465.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.89 to $10.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":116697,"source":{"system":"sec-edgar","filing":"0001104659-21-025572","document":"tm217272-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665280/000110465921025572/tm217272-1_4seq1.xml","form_type":"4"}},{"id":4121497,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-27T02:55:22.000Z","date":"2017-12-21","kind":"other","acquired":true,"shares":79560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from HCFP/Capital Partners III LLC, of which the reporting person is a non-managing member."}],"balance_after":163177,"source":{"system":"sec-edgar","filing":"0001094891-17-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489117000288/edgar.xml","form_type":"4"}},{"id":4542558,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2016-11-23T16:08:38.000Z","date":"2016-11-22","kind":"purchase","acquired":true,"shares":100,"price":6.4,"value":640.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":100,"derivative":{"exercise_price":5,"exercise_date":"2016-10-28","expiration_date":"2022-01-29","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001094891-16-000649","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489116000649/edgar.xml","form_type":"4"}},{"id":4544535,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T21:08:19.000Z","date":"2016-11-18","kind":"purchase","acquired":true,"shares":100,"price":11.51,"value":1151.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001094891-16-000647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489116000647/edgar.xml","form_type":"4"}},{"id":4544534,"issuer":{"id":7317,"kind":"organization","name":"PAVmed Inc."},"owners":[{"id":133075,"kind":"person","name":"Lamstein Joshua R","position":1,"cik":"0001665280","reported_name":"Lamstein Joshua R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-22T21:08:19.000Z","date":"2016-11-18","kind":"purchase","acquired":true,"shares":100,"price":10.38,"value":1038.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001094891-16-000647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624326/000109489116000647/edgar.xml","form_type":"4"}}]}